NeraCare
Latest round
- Series A
Last raised
- Mar 2020
Total raised
- $8.8M
Investors
- 2
About NeraCare
NeraCare GmbH is a biotechnology company specializing in advanced therapeutic products focused on regenerative medicine, particularly for skin healing and tissue repair.Founded in 2015, NeraCare GmbH operates in Cologne, Germany. The company is dedicated to developing therapeutic solutions for medical conditions, particularly in regenerative medicine.NeraCare specializes in innovative solutions within the biotechnology sector, focusing on the development of advanced therapeutic products aimed at addressing a range of medical conditions. The company’s core offerings include proprietary formulations designed for regenerative medicine, particularly in the areas of skin healing and tissue repair. These products are engineered to enhance healing processes, making them suitable for use in clinical settings, including hospitals and outpatient facilities. NeraCare targets a diverse customer base that includes healthcare providers, dermatology clinics, and pharmaceutical companies, primarily in the European and North American markets.NeraCare's revenue model is structured around direct sales and partnerships within the healthcare ecosystem, facilitating transactions between the company and its clinical clients. The company engages in B2B relationships, providing its therapeutic products to hospitals and medical facilities that utilize them in patient treatments. These transactions may involve bulk orders or subscription-based agreements where healthcare providers receive regular shipments of the products. NeraCare’s flagship offerings are positioned at competitive price points, designed to ensure accessibility while reflecting the advanced technology and research underpinning each product.NeraCare GmbH is focused on launching new products designed for regenerative medicine, with specific emphasis on skin healing technologies. Additionally, NeraCare plans to expand into North American markets by 2023, aiming to strengthen its presence while catering to a broader customer base. This strategy is underpinned by their commitment to innovation and market responsiveness.
Who invested in NeraCare
2 investors across 1 round
See all investors in NeraCare
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 5, 2020
Amount
$8.8M
Investors
Questions about NeraCare
Who invested in NeraCare?
NeraCare has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeraCare raised?
NeraCare has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NeraCare last raise money?
NeraCare's most recent round on record is a Series A, in Mar 2020.
What does NeraCare do?
NeraCare GmbH is a biotechnology company specializing in advanced therapeutic products focused on regenerative medicine, particularly for skin healing and tissue repair.
Where is NeraCare headquartered?
NeraCare is headquartered in Cologne, Germany.
Which VCs invest in companies like NeraCare?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at NeraCare's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like NeraCare? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.